๐ฐ Leukemia News
Page 112 - Leukemia News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Leukemia. Real-time updates on events, politics, business and more.
June 28, 2023
An experimental antibody treatment largely prevented a bone marrow transplant complication called graft versus host disease (GVHD) in the intestines, without causing broad immune suppression, in a preclinical study led by researchers from Penn Medicine and Dana-Farber/Boston Children's Cancer and Blood Disorders Center and published today in Science Translational Medicine.
June 27, 2023
You got to give him credit. hes a loyal retriever. dare devils race for the prize in glouster, massachusetts. they had to run across grease telephone pole. they plunge up to 20 feet into the water, win or lose. take a look at this video of a curious giraffe inspecting a baby deer. the global wildlife center says jet, named after a visitors son who passed away from leukemia, is both sweet and goofy. he spends time with three of his offspring something that male giraffes dont typically do. if yo...
June 27, 2023
The future of cancer treatment may involve two modern technologies: mRNA and CAR T Therapy. Here, we describe an example using multiple myeloma.
June 26, 2023
Leukemia is the most serious consequence of exposure to benzene, a pollutant from gas appliances. A physician looks at data on leukemia risk among smokers.
June 26, 2023
Singer-songwriter Andrew McMahon is not the same person he was before his leukemia diagnosis, and thatโs OK, he said.
June 25, 2023
The number of registered donors stood at about 544,000 at the end of March this year, an increase of only about 6,500 from a year earlier.
June 23, 2023
India News: HYDERABAD: Pharma player Aurobindo Pharma Ltd on Friday informed the bourses that its wholly owned subsidiary, Eugia Pharma Specialities Ltd, has ente.
June 21, 2023
The FDA has granted regular approval to blinatumomab (Blincyto) for the treatment of adult and pediatric patients with CD19-positive B-cell precursor acute lymphoblastic leukemia in first or second complete remission with minimal residual disease of at least 0.1%
June 21, 2023
The full approval is based on data showing that 80% of patients with B-ALL experienced a complete MRD response.